{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:44:29Z","timestamp":1762548269495,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005525","name":"Society of Toxicology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005525","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019535","name":"Texas Tech University Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003898","name":"Dan Jansen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ymthe.2024.07.029","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T22:27:09Z","timestamp":1722637629000},"page":"3145-3162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy"],"prefix":"10.1016","volume":"32","author":[{"given":"Shreyas","family":"Gaikwad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8989-0438","authenticated-orcid":false,"given":"Sanjay K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.07.029_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41416-019-0479-5","article-title":"Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features","volume":"121","author":"Karamitopoulou","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2024.07.029_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13046-023-02935-3","article-title":"Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept","volume":"43","author":"Luo","year":"2024","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.07.029_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1020888","article-title":"Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components","volume":"9","author":"Hsu","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2024.07.029_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.canlet.2015.12.020","article-title":"Current progress in immunotherapy for pancreatic cancer","volume":"381","author":"Foley","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2024.07.029_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.01.031","article-title":"Trials and tribulations of pancreatic cancer immunotherapy","volume":"504","author":"Principe","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2024.07.029_bib7","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.07.029_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/jso.26312","article-title":"Immunotherapy for pancreatic ductal adenocarcinoma","volume":"123","author":"Carpenter","year":"2021","journal-title":"J.\u00a0Surg. Oncol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/1471-2407-13-436","article-title":"The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays","volume":"13","author":"Tewari","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ymthe.2024.07.029_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1200\/EDBK_175232","article-title":"Deploying Immunotherapy in Pancreatic Cancer: Defining Mechanisms of Response and Resistance","volume":"37","author":"Beatty","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.ymthe.2024.07.029_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.20517\/cdr.2022.142","article-title":"Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma","volume":"6","author":"Akhuba","year":"2023","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.ymthe.2024.07.029_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.semcancer.2020.01.008","article-title":"Repurposing drugs in oncology: From candidate selection to clinical adoption","volume":"68","author":"Pantziarka","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41523-021-00229-5","article-title":"Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer","volume":"7","author":"Draganov","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ymthe.2024.07.029_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cvsm.2011.12.005","article-title":"Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats","volume":"42","author":"Merola","year":"2012","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.ymthe.2024.07.029_bib15","article-title":"Repositioning of Antiparasitic Drugs for Tumor Treatment","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/chromsci\/bmt142","article-title":"An LC-MS method for determination of milbemycin oxime in dog plasma","volume":"52","author":"Xu","year":"2014","journal-title":"J.\u00a0Chromatogr. Sci."},{"key":"10.1016\/j.ymthe.2024.07.029_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/chromsci\/bmt142","article-title":"An\u00a0LC-MS method for determination of milbemycin oxime in dog plasma","volume":"52","author":"Qianqian","year":"2014","journal-title":"J.\u00a0Chromatogr. Sci."},{"key":"10.1016\/j.ymthe.2024.07.029_bib18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.07.029_bib19","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.3390\/curroncol30040293","article-title":"Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights","volume":"30","author":"Balsano","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.20892\/j.issn.2095-3941.2021.0491","article-title":"Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers","volume":"18","author":"Yu","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ymthe.2024.07.029_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semcancer.2020.03.011","article-title":"Drug rechanneling: A novel paradigm for cancer treatment","volume":"68","author":"Kaushik","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib22","article-title":"Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates","volume":"13","author":"De","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2024.07.029_bib23","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.3390\/cancers13225661","article-title":"A Novel Autophagy Modulator for Pancreatic Cancer Treatment","volume":"13","author":"Ramachandran","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2024.07.029_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061374","article-title":"Next Generation of Cancer Drug Repurposing: Therapeutic Combination of Aspirin and Oseltamivir Phosphate Potentiates Gemcitabine to Disable Key Survival Pathways Critical for Pancreatic Cancer Progression","volume":"14","author":"Qorri","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2024.07.029_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092141","article-title":"Pimozide Suppresses the Growth of Brain Tumors by Targeting STAT3-Mediated Autophagy","volume":"9","author":"Ranjan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2024.07.029_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105150","article-title":"Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells","volume":"22","author":"Gupta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.07.029_bib27","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.ymthe.2022.03.012","article-title":"GABA(A) receptor agonist suppresses pediatric medulloblastoma progression by inhibiting PKA-Gli1 signaling axis","volume":"30","author":"Kaushik","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.07.029_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.semcancer.2019.10.007","article-title":"Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy","volume":"68","author":"Shaw","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123628","article-title":"Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug\u00a0Uptake and Processing","volume":"12","author":"Amrutkar","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2024.07.029_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171052","article-title":"Repositioning approved drugs for the treatment of problematic cancers using a screening approach","volume":"12","author":"Varbanov","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.07.029_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238127","article-title":"Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway","volume":"27","author":"Limbu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ymthe.2024.07.029_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1349-7006.2004.tb03330.x","article-title":"Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation","volume":"95","author":"Esumi","year":"2004","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ymthe.2024.07.029_bib33","series-title":"Presented at: International Conference on Drug Discovery and Translational Medicine 2018 (ICDDTM '18)","article-title":"Controversial truth: human pancreatic cancer cell line homes cancer stem cells","author":"Teh","year":"2019"},{"key":"10.1016\/j.ymthe.2024.07.029_bib34","article-title":"Clonogenic assay: adherent cells","volume":"xx","author":"Rafehi","year":"2011","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2024.07.029_bib35","first-page":"1348","article-title":"Moxidectin inhibits glioma cell viability by inducing G0\/G1 cell cycle arrest and apoptosis","volume":"40","author":"Song","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ymthe.2024.07.029_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12935-016-0315-4","article-title":"Induction of G1-phase cell cycle arrest and apoptosis pathway in MDA-MB-231 human breast cancer cells by sulfated polysaccharide extracted from Laurencia papillosa","volume":"16","author":"Murad","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ymthe.2024.07.029_bib38","article-title":"Degradation strategy of cyclin D1 in cancer cells and the potential clinical application","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/0008-5472.CAN-22-0391","article-title":"Combination Therapies with CDK4\/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer","volume":"83","author":"Goodwin","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.07.029_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2022.03.014","article-title":"Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy","volume":"86","author":"Gaikwad","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib41","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020594","article-title":"Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development","volume":"19","author":"Montico","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.07.029_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081564","article-title":"An Overview on Immunogenic Cell Death in Cancer Biology and Therapy","volume":"14","author":"Rodrigues","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2024.07.029_bib44","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.15252\/emmm.201404084","article-title":"The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer","volume":"6","author":"Melotti","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2024.07.029_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076446","article-title":"Anthelmintic Drugs as Emerging Immune Modulators in Cancer","volume":"24","author":"Stolfi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.07.029_bib46","article-title":"Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells","volume":"12","author":"Di","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2024.07.029_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biomaterials.2016.06.032","article-title":"Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy","volume":"102","author":"Zhao","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2024.07.029_bib48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.omto.2022.01.010","article-title":"The next wave of cellular immunotherapies in pancreatic cancer","volume":"24","author":"Yeo","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2024.07.029_bib49","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.3748\/wjg.v27.i46.7956","article-title":"T cells in pancreatic cancer stroma","volume":"27","author":"Goulart","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib50","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1172\/JCI123540","article-title":"Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer","volume":"129","author":"Sivaram","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.07.029_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s40425-019-0573-5","article-title":"STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models","volume":"7","author":"Jing","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.07.029_bib52","article-title":"STING Signaling Drives Production of Innate Cytokines, Generation of CD8(+) T\u00a0Cells and Enhanced Protection Against Trypanosoma cruzi Infection","volume":"12","author":"Vieira","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib53","article-title":"Endothelial STING controls T\u00a0cell transmigration in an IFNI-dependent manner","volume":"6","author":"Anastasiou","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2024.07.029_bib54","doi-asserted-by":"crossref","DOI":"10.1007\/s12038-024-00441-y","article-title":"Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy","volume":"49","author":"Reghu","year":"2024","journal-title":"J.\u00a0Biosci."},{"key":"10.1016\/j.ymthe.2024.07.029_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102872","article-title":"The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer","volume":"12","author":"Orlandella","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2024.07.029_bib56","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1158\/1078-0432.CCR-18-0900","article-title":"Immunotherapy in Pancreatic Adenocarcinoma: Beyond \"Copy\/Paste","volume":"27","author":"Hester","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.07.029_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/biom11050706","article-title":"Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47\/SIRPalpha and TIGIT\/PVR Pathways for Cancer Immuno-Therapy","volume":"11","author":"Zhou","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2024.07.029_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s40425-019-0733-7","article-title":"Niclosamide, an antihelmintic drug, enhances efficacy of PD-1\/PD-L1 immune checkpoint blockade in non-small cell lung cancer","volume":"7","author":"Luo","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.07.029_bib59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.canlet.2019.05.026","article-title":"The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation","volume":"459","author":"Li","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2024.07.029_bib60","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: Relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2024.07.029_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.934746","article-title":"Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction","volume":"13","author":"Lee","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2024.07.029_bib62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/jvp.12375","article-title":"Safety evaluation of orally administered afoxolaner and milbemycin oxime in eight-week-old dogs","volume":"40","author":"Drag","year":"2017","journal-title":"J.\u00a0Vet. Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2024.07.029_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.omto.2020.08.019","article-title":"Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy","volume":"19","author":"Ramachandran","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2024.07.029_bib64","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/0008-5472.CAN-15-1233","article-title":"Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis","volume":"76","author":"Ranjan","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.07.029_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/srep26165","article-title":"Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis","volume":"6","author":"Ranjan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.07.029_bib66","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/mol.110.063750","article-title":"Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2\/M cell cycle arrest in human ovarian cancer cells","volume":"78","author":"Kandala","year":"2010","journal-title":"Mol. Pharmacol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624005227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624005227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:41:19Z","timestamp":1762548079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624005227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":66,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1525001624005227"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.07.029","relation":{},"ISSN":["1525-0016"],"issn-type":[{"type":"print","value":"1525-0016"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}